» Articles » PMID: 25885919

Mechanisms Involved in Breast Cancer Liver Metastasis

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2015 Apr 18
PMID 25885919
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Liver metastasis is a frequent occurrence in patients with breast cancer; however, the available treatments are limited and ineffective. While liver-specific homing of breast cancer cells is an important feature of metastasis, the formation of liver metastases is not random. Indeed, breast cancer cell factors contribute to the liver microenvironment. Major breakthroughs have been achieved recently in understanding breast cancer liver metastasis (BCLM). The process of liver metastasis consists of multiple steps and involves various factors from breast cancer cells and the liver microenvironment. A further understanding of the roles of breast cancer cells and the liver microenvironment is crucial to guide future work in clinical treatments. In this review we discuss the contribution of breast cancer cells and the liver microenvironment to liver metastasis, with the aim to improve therapeutic efficacy for patients with BCLM.

Citing Articles

Liver resection for breast cancer-related liver metastases: a case report.

Pangarsa E, Prabowo E, Subiyakto , Yudisaputro W, Istiadi H, Hadiyanto J J Med Case Rep. 2024; 18(1):635.

PMID: 39710686 PMC: 11665236. DOI: 10.1186/s13256-024-05001-4.


Molecular docking and / studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer.

Alqahtani N, Alfaifi M, Shati A A, Elbehairi S, Saleh A, Kotb E RSC Adv. 2024; 14(52):39027-39039.

PMID: 39659603 PMC: 11629753. DOI: 10.1039/d4ra06398h.


Male breast cancer metastasising to the liver: A case report.

Jiang M, Li L, Liu H, Xie H Oncol Lett. 2024; 28(5):530.

PMID: 39290955 PMC: 11406569. DOI: 10.3892/ol.2024.14663.


Concise review: breast cancer stems cells and their role in metastases.

Farahani M, Farjadmehr M, Atashi A, Momeni A, Behzadifard M Ann Med Surg (Lond). 2024; 86(9):5266-5275.

PMID: 39238997 PMC: 11374310. DOI: 10.1097/MS9.0000000000002270.


State of the Art Modelling of the Breast Cancer Metastatic Microenvironment: Where Are We?.

Nuckhir M, Withey D, Cabral S, Harrison H, Clarke R J Mammary Gland Biol Neoplasia. 2024; 29(1):14.

PMID: 39012440 PMC: 11252219. DOI: 10.1007/s10911-024-09567-z.


References
1.
Erin N, Wang N, Xin P, Bui V, Weisz J, Barkan G . Altered gene expression in breast cancer liver metastases. Int J Cancer. 2009; 124(7):1503-16. DOI: 10.1002/ijc.24131. View

2.
Eichbaum C, Meyer A, Wang N, Bischofs E, Steinborn A, Bruckner T . Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis. Anticancer Res. 2011; 31(10):3219-27. View

3.
Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H . High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat. 2004; 86(3):207-13. DOI: 10.1023/B:BREA.0000036787.59816.01. View

4.
Khatib A, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M . Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol. 2005; 167(3):749-59. PMC: 1698732. DOI: 10.1016/S0002-9440(10)62048-2. View

5.
Grano M, Mori G, Minielli V, Colucci S, Vaira S, Giannelli G . HGF and M-CSF modulate adhesion of MDA-231 breast cancer cell by increasing osteopontin secretion. J Biol Regul Homeost Agents. 2002; 16(3):190-5. View